tldrdaily.news logo

Novo Nordisk Cuts Ozempic Price to $499 for Cash Patients

1 min read
Source: Financial Times
Novo Nordisk Cuts Ozempic Price to $499 for Cash Patients
Photo: Financial Times
TL;DR Summary

Novo Nordisk has halved the US price of Ozempic, a popular diabetes medication, as part of its efforts to improve accessibility and address concerns over drug pricing.

Topics:top-news#business#diabetes-medication#novo-nordisk#ozempic#pharmaceutical-pricing#us-price-reduction
Share this article
  1. Novo Nordisk halves US price of Ozempic  Financial Times
  2. Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients  CNBC
  3. GoodRx stock soars after striking deal to sell Novo Nordisk's GLP-1s for $499/month  Yahoo Finance
  4. Novo Halves Ozempic Price to $499 a Month for Those Paying Cash  Bloomberg.com
  5. GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic  Business Wire

Reading Insights

Total Reads

0

Unique Readers

1

Time Saved

1 min

vs 1 min read

Condensed

80%

135 → 27 words

Want the full story? Read the original article

Read on Financial Times